Dear Research Advocate: Speaking recently to the “New Voices” group at the National Academies of Science, Engineering and Medicine, as well as to young scientists during a visit to the University of Miami, I was energized by the passion, determination and commitment they all have for engaging the public. I discussed highlights of the survey findings we feature in Research!America’s new poll data summary A new survey question probes awareness and support for engagement of scientists in the policy making process. Other survey highlights include trend data that might surprise you — like the 10% increase since 2015 in those who say they would be willing to pay more in taxes if the money went to...
Dear Research Advocate: Yesterday was the first day of spring and with it comes the hustle and bustle of appropriations season. Rumor has it House Appropriations Chairwoman Nita Lowey (D-NY) plans to begin marking up fiscal year (FY) 2020 legislation as soon as late April with a Defense/Labor-HHS mini package among the first bills. It is therefore urgent we make the case now, with one voice, for strong FY20 research funding. Deadlines are close: Members of Congress must submit their individual requests to the House Labor, Health and Human Services, Education (Labor-H) Subcommittee by March 28, the Agriculture, FDA Subcommittee by April 4, and to the Commerce, Justice, Science (CJS)...
Designed to reduce the federal deficit, the Budget Control Act of 2011 placed strict, austerity-level “sequestration” caps on federal spending when Congress failed to develop a responsible plan for reducing the national budget. The caps are not a legitimate, thoughtfully designed policy suggestion, but rather a fallback budget mechanism—a blunt instrument that ignores current national threats and opportunities, and does not account for the strategic interests of our nation. Historically, Congress has been aware of this issue and responded accordingly, acting every two years to modify the Budget Control Act and increase the level of discretionary spending appropriated each year. More...
Dear Research Advocate: First, thank you! It was so meaningful to celebrate our 30th anniversary with so many of you at our annual meeting and advocacy awards dinner yesterday. It is difficult to do the day justice or fully express my gratitude for it. Check our website next week for a livestream of the annual meeting, which featured Assistant Secretary of Health and Human Services (HHS) Admiral Brett Giroir; NIH National Heart, Lung, and Blood Institute (NHLBI) Director Dr. Gary Gibbons; a candid discussion between Massachusetts Institute of Technology (MIT) President Emerita, Dr. Susan Hockfield and Seema Kumar of Johnson & Johnson; and the heartfelt story of cystic fibrosis patient...
Dear Research Advocate: A Senate HELP Committee hearing this week examined what is driving preventable disease outbreaks. A key issue of discussion – as observed in our 2018 survey data – is growing public suspicion about the benefit of vaccines. The hearing also focused on the need for a robust public health infrastructure that can prevent public health threats. In a New York Times op-ed published yesterday, Admiral Brett Giroir, Assistant Secretary of HHS, Dr. Robert Redfield, Director of CDC, and Vice Admiral Jerome Adams, U.S. Surgeon General, noted that vaccines have proven so successful that many clinicians and parents may not realize the seriousness of diseases – such as measles –...

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana